SCHEMBL20914166

SCHEMBL20914166

Cc1[nH]c2c(-c3ccccc3)c(C(F)(F)F)nn2c(=O)c1-c1nnc(N)o1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ NOTUM Q6P988 1/20 0.39
▸ ARF6 P62330 5/20 0.38
▸ PDGFRA P16234 1/20 0.35
▸ MAPK8 P45983 1/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ CLK4 Q9HAZ1 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.34
▸ PLAT P00750 1/20 0.34
▸ CMA1 P23946 1/20 0.34
▸ HPGD P15428 1/20 0.33
▸ CDK8 P49336 1/20 0.33
▸ ACVR1 Q04771 1/20 0.33
▸ SLC11A2 P49281 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20914070 0.91 POLB (0.41) POLBALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL20819013 0.90 POLB (0.41) POLBALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL20914314 0.89 NPC1 (0.43) POLBALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL20914276 0.89 ALDH1A1 (0.41) POLBALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL20914419 0.88 MECP2 (0.45) POLBALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL20913897 0.87 POLB (0.39) POLBALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL20914182 0.86 ALDH1A1 (0.38) POLBALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL20914109 0.86 NOTUM (0.41) POLBALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL20914340 0.86 ARF6 (0.37) POLBALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL20914201 0.85 NPC1 (0.43) POLBALDH1A1MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof NLRP3, NLRP1, P2RX7 POLB 4311/4885ALDH1A1 1246/4885MEN1 2785/4885
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF NLRP3, NLRP1, P2RX7 POLB 4311/4885ALDH1A1 1246/4885MEN1 2785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback